Your trusted adviser for R&D Tax Credits, Creative Tax Relief, and R&D Grants
Your trusted adviser for R&D Tax Credits, Creative Tax Relief, and R&D Grants
Explore our news page for thought leadership articles, technical expertise and the latest developments in the world of innovation funding.
Filter
The specialist R&D tax credit team at Myriad has once again been successful in its client’s appeal to the First-Tier Tax Tribunal.
The Grants team at Myriad Associates are proud to announce that they have secured over €30m from the Disruptive Technologies Innovation Fund (DTIF).
Onkimmune was founded in 2015 with the goal of developing novel anti-cancer therapies using Natural Killer (NK) cells.
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.
hello@myriadassociates.com